第 1 到 12 筆結果,共 12 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways | YU-TING CHANG ; Peng, Hsuan-Yu; Hu, Chun-Mei; Tien, Sui-Chih; Chen, Yi-Ing; YUNG-MING JENG ; Chang, Ming-Chu | Molecular oncology | 2 | 1 | |
2 | 2021 | Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer | Wu, Heng-Hsiung; Tsai, Lung-Hung; Huang, Chun-Kai; Hsu, Pang-Hung; Chen, Mei-Yu; Chen, Yi-Ing; Hu, Chun-Mei; Shen, Chia-Ning; Lee, Chen-Chen; MING-CHU CHANG ; YU-TING CHANG ; YU-WEN TIEN ; YUNG-MING JENG ; Lee, Eva Y-H P; Lee, Wen-Hwa | Science translational medicine | 12 | 11 | |
3 | 2020 | Validation of Indications for Surgery of European Evidence-Based Guidelines for Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms | I-SHIOW JAN ; MING-CHU CHANG ; CHING-YAO YANG ; YU-WEN TIEN ; YUNG-MING JENG ; CHIH-HORNG WU ; BANG-BIN CHEN ; YU-TING CHANG | Journal of Gastrointestinal Surgery | 14 | 16 | |
4 | 2019 | High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells | Hu C.-M.; Tien S.-C.; Hsieh P.-K.; YUNG-MING JENG ; MING-CHU CHANG ; YU-TING CHANG ; Chen Y.-J.; Chen Y.-J.; Lee E.Y.-H.P.; Lee W.-H. | Cell Metabolism | 71 | 66 | |
5 | 2017 | Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan | MING-CHU CHANG ; CHIH-HORNG WU ; SHIH HUNG YANG ; PO-CHIN LIANG ; BANG-BIN CHEN ; I-SHIOW JAN ; YU-TING CHANG ; YUNG-MING JENG | American Journal of Cancer Research | 15 | ||
6 | 2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | MING-CHU CHANG ; YU-TING CHANG ; Chen J.-Y.; YUNG-MING JENG ; CHING-YAO YANG ; YU-WEN TIEN ; SHIH-HUNG YANG ; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 75 | 69 | |
7 | 2015 | Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma | CHING-YAO YANG ; JAU-YU LIAU ; Huang W.-J.; YU-TING CHANG ; MING-CHU CHANG ; JEN-CHIEH LEE ; JIA-HUEI TSAI ; Su Y.-N.; Hung C.-C.; YUNG-MING JENG | American Journal of Translational Research | 43 | ||
8 | 2015 | Overweight Increases the Risk of Malignancy in Patients with Pancreatic Mucinous Cystic Neoplasms | YU-TING CHANG ; YU-WEN TIEN ; YUNG-MING JENG ; CHING-YAO YANG ; PO-CHIN LIANG ; Wong J.-M.; MING-CHU CHANG | Medicine (United States) | 7 | 6 | |
9 | 2015 | Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment | MING-CHU CHANG ; I-SHIOW JAN ; PO-CHIN LIANG ; YUNG-MING JENG ; CHING-YAO YANG ; YU-WEN TIEN ; Wong J.-M.; YU-TING CHANG | Journal of Cystic Fibrosis | 7 | 6 | |
10 | 2014 | Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis | MING-CHU CHANG ; I-SHIOW JAN ; PO-CHIN LIANG ; YUNG-MING JENG ; CHING-YAO YANG ; YU-WEN TIEN ; Wong J.-M.; YU-TING CHANG | Journal of Gastroenterology and Hepatology (Australia) | 27 | 23 | |
11 | 2009 | Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival | Ying-Chun Shen ; Hu F.-C.; YUNG-MING JENG ; YU-TING CHANG ; ZHONG-ZHE LIN ; MING-CHU CHANG ; CHIUN HSU ; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 21 | 20 | |
12 | 2007 | Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma | YU-TING CHANG ; CHIUN HSU ; YUNG-MING JENG ; MING-CHU CHANG ; SHU-CHEN WEI ; Wong J.-M. | Journal of Gastroenterology and Hepatology (Australia) | 24 | 24 |